Such discrepancies might be attributed to the differences in the number of cases in each subtype between the Nottingham and METABRIC cohorts or might be due to tumour-specific differences in NOP10 mRNA/protein stability or post-transcriptional regulation of NOP10 expression. This evidence concerns the gene NOP10 and neoplasm.